Prime Medicine

Gene editing company advancing prime editing technology to develop a new class of genetic medicines capable of making virtually any type of edit to the genome with high precision.

Location
Cambridge, Massachusetts, USA
Founded
2019
Investors
3
Categories
biotech, gene-editing, prime-editing, therapeutics

Investors

NameLocationTypeStagesPortfolio
CE-Ventures (Crescent Enterprises)Sharjah, UAEgeneralist
seedseries-a+3
4
F-Prime CapitalCambridge, USAbiotech-focused
seedseries-a+2
2
ARCH Venture PartnersChicago, USAbiotech-focused
seedseries-a+3
6